The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Kura Oncology Inc shares valued at $103,980 were sold by DALE STEPHEN on Jan 30 ’24. At $21.55 per share, DALE STEPHEN sold 4,825 shares. The insider’s holdings dropped to 38,817 shares worth approximately $0.82 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, DALE STEPHEN sold 7,158 shares, netting a total of over 127,416 in proceeds. Following the sale of shares at $17.80 each, the insider now holds 43,642 shares.
Before that, DOYLE THOMAS JAMES had sold 2,318 shares from its account. In a trade valued at $41,262, the SVP, Finance & Accounting traded Kura Oncology Inc shares for $17.80 each. Upon closing the transaction, the insider’s holdings decreased to 2,318 shares, worth approximately $1.02 million.
As published in their initiating research note from Mizuho on December 22, 2023, Kura Oncology Inc [KURA] has been a Buy and the price target has been revised to $26. Analysts at BofA Securities started covering the stock with ‘”a Buy”‘ outlook in a report released in mid August. As of July 27, 2023, Scotiabank has initiated its “Sector perform” rating for KURA. Earlier on May 17, 2023, BTIG Research initiated its rating. Their recommendation was “a Buy” for KURA stock.
Analyzing KURA Stock Performance
During the last five days, there has been a drop of approximately -3.51%. Over the course of the year, Kura Oncology Inc shares have jumped approximately 47.22%. Shares of the company reached a 52-week high of $24.17 on 03/11/24 and a 52-week low of $13.29 on 01/23/24. A 50-day SMA is recorded $20.24, while a 200-day SMA reached $12.89. Nevertheless, trading volume fell to 0.64 million shares from 0.48 million shares the previous day.
Support And Resistance Levels for Kura Oncology Inc (KURA)
According to the 24-hour chart, there is a support level at 20.55, which, if violated, would cause prices to drop to 19.92. In the upper region, resistance lies at 21.51. The next price resistance is at 21.85. RSI (Relative Strength Index) is 50.26 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.98, which suggests the price will decrease in the coming days. Percent R is at 76.82%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
Is Kura Oncology Inc subject to short interest?
Stocks of Kura Oncology Inc saw a sharp rise in short interest on Feb 29, 2024 jumping by 1.65 million shares to 11.02 million. Data from Yahoo Finance shows that the short interest on Jan 31, 2024 was 9.37 million shares. A jump of 14.97% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 7.71 of the overall float, the days-to-cover ratio (short ratio) jumped to 7.71.
